RecallDepth
Class III Terminated

Mercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com

This recall has been terminated (originally issued March 13, 2024).

Company
Stason Pharmaceuticals, Inc.
Recall Initiated
February 9, 2024
Posted
March 13, 2024
Recall Number
D-0367-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
54, 131 bottles
Firm Location
Irvine, CA, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: results slightly under spec at at 9-months.

Distribution

USA Nationwide

Lot / Code Info

Lot #: a)22K012, 22K013A, Exp: 04/30/2024; 23A001, 23A002A, Exp: 07/31/2024; 23D006, 23D007A, 23D007C, Exp:10/31/2024; b)22K013B, Exp: 04/30/2024; 23A002B, Exp:07/31/2024; 23D007B, Exp: 10/31/2024.

More recalls by Stason Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class III Drug recalls